Tag: Dr. Alexa B. Kimball

FDA approves Novartis’ Cosentyx for hidradenitis suppurativa treatment

Novartis, a global leader in immuno-dermatology and rheumatology, announced the U.S. Food and Drug Administration's approval of Cosentyx (secukinumab) for treating adults with moderate to ... Read More